United States Penciclovir Market Report 2016

December 2016 | 111 pages | ID: U3C312CEA84EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Penciclovir

Revenue, means the sales value of Penciclovir

This report studies sales (consumption) of Penciclovir in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Agenus, Inc. (US)
• AiCuris GmbH & Co.KG (Germany)
• Vical (US)
• Sanofi (France)
• Cytogenix, Inc. (US)
• Genocea Biosciences (US)
• GlaxoSmithKline Plc. (UK)
• Lumavita AG (Switzerland)
• NanoBio Corporation (US)
• Starpharma Holdings Limited (Australia)
• Novartis International AG (Switzerland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Penciclovir in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Penciclovir Market Report 2016

1 PENCICLOVIR OVERVIEW

1.1 Product Overview and Scope of Penciclovir
1.2 Classification of Penciclovir
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Penciclovir
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Penciclovir (2011-2021)
  1.4.1 United States Penciclovir Sales and Growth Rate (2011-2021)
  1.4.2 United States Penciclovir Revenue and Growth Rate (2011-2021)

2 UNITED STATES PENCICLOVIR COMPETITION BY MANUFACTURERS

2.1 United States Penciclovir Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Penciclovir Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Penciclovir Average Price by Manufactures (2015 and 2016)
2.4 Penciclovir Market Competitive Situation and Trends
  2.4.1 Penciclovir Market Concentration Rate
  2.4.2 Penciclovir Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PENCICLOVIR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Penciclovir Sales and Market Share by Type (2011-2016)
3.2 United States Penciclovir Revenue and Market Share by Type (2011-2016)
3.3 United States Penciclovir Price by Type (2011-2016)
3.4 United States Penciclovir Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PENCICLOVIR SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Penciclovir Sales and Market Share by Application (2011-2016)
4.2 United States Penciclovir Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PENCICLOVIR MANUFACTURERS PROFILES/ANALYSIS

5.1 Agenus, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Penciclovir Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Agenus, Inc. (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AiCuris GmbH & Co.KG (Germany)
  5.2.2 Penciclovir Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AiCuris GmbH & Co.KG (Germany) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Vical (US)
  5.3.2 Penciclovir Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Vical (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi (France)
  5.4.2 Penciclovir Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi (France) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Cytogenix, Inc. (US)
  5.5.2 Penciclovir Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Cytogenix, Inc. (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Genocea Biosciences (US)
  5.6.2 Penciclovir Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Genocea Biosciences (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 GlaxoSmithKline Plc. (UK)
  5.7.2 Penciclovir Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 GlaxoSmithKline Plc. (UK) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Lumavita AG (Switzerland)
  5.8.2 Penciclovir Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Lumavita AG (Switzerland) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 NanoBio Corporation (US)
  5.9.2 Penciclovir Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 NanoBio Corporation (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Starpharma Holdings Limited (Australia)
  5.10.2 Penciclovir Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Starpharma Holdings Limited (Australia) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Novartis International AG (Switzerland)

6 PENCICLOVIR MANUFACTURING COST ANALYSIS

6.1 Penciclovir Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Penciclovir

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Penciclovir Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Penciclovir Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PENCICLOVIR MARKET FORECAST (2016-2021)

10.1 United States Penciclovir Sales, Revenue Forecast (2016-2021)
10.2 United States Penciclovir Sales Forecast by Type (2016-2021)
10.3 United States Penciclovir Sales Forecast by Application (2016-2021)
10.4 Penciclovir Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Penciclovir
Table Classification of Penciclovir
Figure United States Sales Market Share of Penciclovir by Type in 2015
Table Application of Penciclovir
Figure United States Sales Market Share of Penciclovir by Application in 2015
Figure United States Penciclovir Sales and Growth Rate (2011-2021)
Figure United States Penciclovir Revenue and Growth Rate (2011-2021)
Table United States Penciclovir Sales of Key Manufacturers (2015 and 2016)
Table United States Penciclovir Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Penciclovir Sales Share by Manufacturers
Figure 2016 Penciclovir Sales Share by Manufacturers
Table United States Penciclovir Revenue by Manufacturers (2015 and 2016)
Table United States Penciclovir Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Penciclovir Revenue Share by Manufacturers
Table 2016 United States Penciclovir Revenue Share by Manufacturers
Table United States Market Penciclovir Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Penciclovir Average Price of Key Manufacturers in 2015
Figure Penciclovir Market Share of Top 3 Manufacturers
Figure Penciclovir Market Share of Top 5 Manufacturers
Table United States Penciclovir Sales by Type (2011-2016)
Table United States Penciclovir Sales Share by Type (2011-2016)
Figure United States Penciclovir Sales Market Share by Type in 2015
Table United States Penciclovir Revenue and Market Share by Type (2011-2016)
Table United States Penciclovir Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Penciclovir by Type (2011-2016)
Table United States Penciclovir Price by Type (2011-2016)
Figure United States Penciclovir Sales Growth Rate by Type (2011-2016)
Table United States Penciclovir Sales by Application (2011-2016)
Table United States Penciclovir Sales Market Share by Application (2011-2016)
Figure United States Penciclovir Sales Market Share by Application in 2015
Table United States Penciclovir Sales Growth Rate by Application (2011-2016)
Figure United States Penciclovir Sales Growth Rate by Application (2011-2016)
Table Agenus, Inc. (US) Basic Information List
Table Agenus, Inc. (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Agenus, Inc. (US) Penciclovir Sales Market Share (2011-2016)
Table AiCuris GmbH & Co.KG (Germany) Basic Information List
Table AiCuris GmbH & Co.KG (Germany) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table AiCuris GmbH & Co.KG (Germany) Penciclovir Sales Market Share (2011-2016)
Table Vical (US) Basic Information List
Table Vical (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical (US) Penciclovir Sales Market Share (2011-2016)
Table Sanofi (France) Basic Information List
Table Sanofi (France) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi (France) Penciclovir Sales Market Share (2011-2016)
Table Cytogenix, Inc. (US) Basic Information List
Table Cytogenix, Inc. (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytogenix, Inc. (US) Penciclovir Sales Market Share (2011-2016)
Table Genocea Biosciences (US) Basic Information List
Table Genocea Biosciences (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genocea Biosciences (US) Penciclovir Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Penciclovir Sales Market Share (2011-2016)
Table Lumavita AG (Switzerland) Basic Information List
Table Lumavita AG (Switzerland) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lumavita AG (Switzerland) Penciclovir Sales Market Share (2011-2016)
Table NanoBio Corporation (US) Basic Information List
Table NanoBio Corporation (US) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table NanoBio Corporation (US) Penciclovir Sales Market Share (2011-2016)
Table Starpharma Holdings Limited (Australia) Basic Information List
Table Starpharma Holdings Limited (Australia) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Starpharma Holdings Limited (Australia) Penciclovir Sales Market Share (2011-2016)
Table Novartis International AG (Switzerland) Basic Information List
Table Novartis International AG (Switzerland) Penciclovir Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International AG (Switzerland) Penciclovir Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Penciclovir
Figure Manufacturing Process Analysis of Penciclovir
Figure Penciclovir Industrial Chain Analysis
Table Raw Materials Sources of Penciclovir Major Manufacturers in 2015
Table Major Buyers of Penciclovir
Table Distributors/Traders List
Figure United States Penciclovir Production and Growth Rate Forecast (2016-2021)
Figure United States Penciclovir Revenue and Growth Rate Forecast (2016-2021)
Table United States Penciclovir Production Forecast by Type (2016-2021)
Table United States Penciclovir Consumption Forecast by Application (2016-2021)